PHARMARON (03759.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Nov17

Kanglong Chemical Beijing Co., Ltd Acquires Biortus to Enhance Its CRO Market Position

09:41

Kanglong Huacheng Acquires Bayoreader for 1346 Million Yuan

09:15

Cinda International Securities Upgrades Kanglong Chemical's Rating and Target Price

08:35

Convergent Science's Shareholders Plan to Reduce Holdings

00:40

Nov14

Major Shareholders of Kanglong Chemical Plan to Reduce Shareholding

12:08

Nov5

Norges Bank Increases Holdings in ChemPartner

11:05

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 3.984 B, Net Income 480.46 M, EPS 0.272

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.658 B, Net Income 433.23 M, EPS 0.2457

Aug6

Distribution Plan(CST)

Cash dividend 0.2187 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change